In the context of a health emergency like the COVID-19 pandemic, the global availability of and access to vaccines are … COVID-19 vaccines and of the market strategies adopted by some of the companies that developed them. It notes that the … development of vaccines was supported by substantial public funding from countries that later received preferential access to …

beginning of vaccination is marked by the deepening of vaccine nationalism, the concentration of inputs and vaccines production … and access to COVID-19 vaccines (and other relevant technologies for control and treatment), the scenario after the … access to vaccines not until 2024. While advanced purchase agreements (APAs) among pharmaceutical companies and some …

development will be financially sustainable for the private sector and that effective vaccines will be available to prevent the …

and the scientific, technological and industrial development of vaccines and find that certain elements of the industry … policies to boost supply and drive demand, paying particular attention to the inequity in the global distribution of vaccines …

Should the intellectual property rights on the first Covid-19 vaccines be temporarily lifted in applying the Trade …-Related Aspect of Intellectual Property (TRIPS) flexibility? Is it right to grant the first generation of Covid-19 vaccines a special … in granting broad worldwide access to vaccination. The accumulated delays in providing effective Covid-19 vaccine …